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ABSTRACT 
Benzoxazinone derivatives fused with other heterocyclic and aromatic ring system were reported to possess various activities such as anti-
inflammatory, analgesic, antimicrobial. The Benzoxazinone are an important group of secondary metabolites occurring in gramineae, 
acanthaceae, and ranunculaceae. Novel 1, 4-benzoxazin-3-one derivative have been synthesized which would have inhibitory activities against 
tyrosine kinases and the inhibitory activities against KDR and ABL which are closely related to chronic disease such as cancer. 1,4 - 
Benzoxazinones has wide application in medicinal chemistry due to its pharmacological properties. The members of this family are used for 
treating parkinsons disease, ischemia reperfusion, selective potassium channel openers, antinociceptive, antidepressant and anti-fungal agent. 
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INTRODUCTION 
The Benzoxazinone are an important group of secondary 
metabolites occurring in gramineae, acanthaceae, and 
ranunculaceae. Their role as defense compounds towards 
pests like bacteria fungi and insects is documented for 
different cereals (Gramineae) including corn, wheat, and rye. 
2H-1, 4-Benzoxazin-3(4H)-one has been identified as an 
intermediate in the biosynthesis of cyclic hydroxamic acids 
in maize by showing that the deuterium labeled compound 
is incorporated into DIMBOA with high retention of 
deuterium and high efficiency, by trapping radioactivity 
from [14C] anthranilic acid in a pool of unlabelled 
benzoxazinone administered to maize shoots, and by 
showing that benzoxazinone is oxidized to DIBOA by maize 
microsomes in an NADPH- and oxygen-dependent reaction.1 
Novel 1, 4-benzoxazin-3-one derivative have been 
synthesized which would have inhibitory activities against 
tyrosine kinases and the inhibitory activities against KDR 
and ABL which are closely related to chronic disease such as 
cancer. A number of new 1-phenyl-(a),1-(3-chlorophenyl)-
(b) and 1-(2-methoxyphenyl), (c) piperzine derivatives 
containing 1,4-benzoxazin-3(4H)-one (2-4), 2,4- benzoxazin-
3(4H)-one (5), 1,2-benzoxazolin-3-one (6) and 1,3- 
benzoxazolin-2,4-dione were synthesized.2 
1,4- Benzoxazinones has wide application in medicinal 
chemistry due to its pharmacological properties .the 
members of this family are used for treating parkinsons 
disease, ischemia reperfusion , selective potassium channel 
openers, antinociceptive, antidepressant and anti-fungal 
agent . Moreover 1, 4- Benzoxazinone used intermediates for 
the synthesis of aza sugers.3 
O
N
H
O
 
Figure1: Molecular structure- 2 H-1, 4- BENZOXAZIN-
3(4H)-one 
Pharmaceutical chemistry occupies the most important 
place among the related sciences but at the same time it is 
dependent on other chemical and biological disciplines. The 
approach to practice medicinal chemistry has developed 
from an empirical one, which involves organic synthesis of 
new compounds, largely based on modification of structures 
of known activity.  For more than a century, heterocyclic 
have constituted one of the largest areas of research in 
organic chemistry. Heterocyclic compounds plays an 
important role in biological process because the side group 
of the most typical and essential constituent of living cells, 
DNA and RNA are based on aromatic heterocyclic. 
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Among the approximately 20 million chemical compounds 
identified by the end of the second millennium, more than 
two third are fully or partially aromatic and approximately 
half are heterocyclic, so we have chosen the heterocyclic 
compound benzoxazinones. Resistance to antimicrobial 
agents has become an increasingly important and pressing 
global problem. Structural modification of antimicrobial 
drugs to which resistance has developed has proven to be an 
effective means of extending the lifespan of antifungal agents 
such as the azoles, antiviral agents such as the non-
nucleoside reverse transcriptase inhibitors, and various 
antibacterial agents.5 
Despite of tremendous progress in human medicines, 
infectious diseases caused by bacteria, fungi, viruses and 
parasites are still a major threat to public health. Their 
impact is particularly large in developing countries due to 
relative unavailability of medicines and the emergence of 
widespread drug resistance. During the last two decades, the 
development of drug resistance as well as the appearance of 
undesirable side effects of certain antibiotics has led to the 
search of new antimicrobial agents mainly among plant 
extracts with the goal to discover new chemical structures, 
which overcome the above disadvantages. Current research 
on natural molecule and products primarily focuses on 
plants since they can be sourced more easily and be selected 
based on their ethno-medicinal uses.6 
Humankind has been subject to infection by microorganism 
since before the dawn of recorded history. One presumes 
that mankind has been searching for suitable therapy for 
nearly as long. This was a desperately difficult enterprise 
given the acute nature of most infections and the nearly total 
lack of understanding of their origins prevalent until the last 
century. Although one can find indications in old medical 
writing of folkloric use of plant and animal preparations, 
soybean curd, moldy bread and cheese, counter infection 
with other microbes, the slow development of public health 
measures, and an understanding of the desirability of 
personal cleanliness, these factors were erratically and 
inefficiently applied and often failed. Until after the 
discovery of bacteria 300 years ago, and subsequent 
understanding of their role in infection about 150 years ago, 
there was no hope for rational therapy.7 
Microbes of soil origin remain to this day the most fruitful 
source of antibiotics, although the specific means employed 
for their discovery are infinitely more sophisticated today 
than those employed 50 years ago. Initially extracts of 
fermentation were screened simply for their ability to kill 
pathogenic microorganisms in vitro. Those that did were 
pushed along through ever more complex pathogenic and 
toxicological tests in attempts to discover clinically useful 
agents. Today many thousands of such extracts of 
increasingly exotic microbes are tested each week and the 
test now includes sophisticated assays for agents operating 
through particular biochemical mechanism or possessing 
desirable properties. The impact of genomics is expected to 
have very substantial impact on this effort. As a consequence 
of this work mankind has now many choices for powerful, 
effective and specific therapy for some of its most ancient 
and common bacterial infections.8 
MATERIAL AND METHODS 
All the melting points reported in this dissertation progress 
report were determined by open capillary method and are 
uncorrected. The synthesis and analytical studies of 
compounds were carried out using laboratory grade and 
analytical grade reagents as the case may be standard 
procedure or reported methods were followed with or 
without modification appropriately as and were required. 
The IR absorption spectra of the compounds were recorded 
on FTIR Bruker Tensor-27 model. 
1. Synthesis of 2 H-1, 4- benzoxazin-3(4H)-one 
A mixture of 2-aminophenol (mol. Wt. 109; 30g) 
(dichloromethane 80ml) and triethylamine (20ml) was 
taken in round bottom flask, in ice cool condition , stirred 
well using magnetic stirrer with simultaneous drop wise 
addition of chloroacetylchloride which was also maintained 
in ice cold condition. The crude product was obtained by 
evaporating dichloromethane. The dried product was boiled 
in water with pinch of decolorizing charcoal until solubilized 
and filtered while hot. The solution thus obtained was 
allowed to cool at 10o C for 30 minutes, filtered and dried. 
The completion of reaction was monitored by running TLC. 9 
2. Synthesis of 4-(2-bromoethyl)-2H-1,4-benzoxazin-
3(4H)-one 
A mixture of benzoxazinone (mol. Wt. 149; 45g) sodium 
ethoxide was taken in round bottom flask, stir well using 
magnetic stirrer, distilled to remove ethanol , then N,N-
dimethylformamide was added mix well ,then 20 ml of 1,2 
dibromoethane was added slowly. Then reflux for 3 hours. 
The crude product was obtained by evaporating N, N 
dimethylformamide on rotary evaporator. The dried product 
was boiled with pinch of decolorizing charcoal until 
solubilized and filtered while hot. The solution thus obtained 
was allowed to cool at 10o C for 30 minutes, filtered and 
dried. The completion of reaction was monitored by running 
TLC.10  
3. Synthesis of substituted piperazine derivatives 
a. Benzyl substitution.(1-phenylcarbonyl)piperazine 
10 g of piperazine was taken in a round bottom flask and 
was dissolved in 15 % of sodium hydroxide and small excess 
of benzoyl chloride was added and shaken vigorously 
benzoylation takes place and small crystal of benzoyl 
derivative separates. Recrystalization was done by 
methanol. The completion of reaction was monitored by 
running TLC.11 
b. Other substitutions  
 10 g of piperazine was taken in a round bottom flask and 
dissolved in 15 ml of ethyl methyl ketone,5 g of the 
respective substituent ( ex. 4-Chloro aniline) was added and 
stirred well and  kept for 5 min. and 3 g of sodium iodide 
stirred well and few ml of HCl was added and refluxed for 3 
hrs. the hot mixture was poured in ice cold water and the ppt 
of the respective substitute was obtained.The ppt was 
recrystalized with the rectified spirit. The completion of 
reaction was monitored by running TLC.12 
4. Synthesis of (4-{2-[4-(phenyl carbonyl) piperazin-1-
yl] ethyl}-2H-1, 4-benzoxazin-3(4H)-one) (4a) 
1g of (1-phenylcarbonyl)piperazine was taken in a round 
bottom flask and was dissolved in dimethylformamide,1gm 
of 4-(2-bromoethyl)-2H-1,4-benzoxazin-3(4H)-one was 
added into it and small quantity of triethylamine was also 
added and refluxed for three hrs. The hot solution was 
poured in to ice cold water and the precipitate of the final 
product was collected and dried in the air. Completion of 
reaction was monitored by running TLC.13 
5. Synthesis of (4-{2-[4-(4-aminophenyl) piperazin-1-yl] 
ethyl}-2H-1, 4-benzoxazin-3(4H)-one) (4b) 
1g of 4-Chloro aniline substituted piperazine was taken in a 
round bottom flask and was dissolved in 
dimethylformamide, 1 g of 4-(2-bromoethyl)-2H-1,4-
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benzoxazin-3(4H)-one was added into it and small quantity 
0f triethylamine was also added and refluxed for three hrs. 
The hot solution was poured in to ice cold water and the 
precipitate of the final product was collected and dried in the 
air. Completion of reaction was monitored by running TLC.14 
RESULTS AND DISCUSSIONS 
First of all the Synthesis of 2 H-1, 4- benzoxazin-3(4H)-one 
was carried out by reacting 2- amino phenol with chloro 
acetyl chloride in dichloromethane in presence of 
triethylamine and then the bromo substitution was done by 
reacting with dibromoethane. Piperazine substituents were 
prepared in laboratory and then the title compounds were 
synthesized. One additional benzoyl substitution was also 
done. The entire synthesized compounds were primarily 
characterized by running T.L.C. and melting point analysis. 
The data which were revealed during the experimental work 
are summarized in tables 1, 2 and 3. 
 
Table 1: The Physicochemical Data of Synthesized Intermediate Compounds 
Compound Mol. formula Mol. Wt. Rf Color 
(Appearance) 
M.P. 
(oC) 
1 C8H7NO2 
 
149 0.40 Pale brownish 
(crystalline) 
108-110 
2 C10H10BrNO2 
 
256 0.72 Light brown 
(crystalline) 
120-122 
3 C11H14N2O 
 
190 0.91 Brown 
Amorphous 
134-138 
 
Table 2: The Physicochemical Data of Synthesized Compounds 
Compound Mol. formula Mol. Wt. Rf Color 
(Appearance) 
M.P. 
(oC) 
4a C21H23N3O3 
 
365 0.96 Pale yellow 
(Crystalline) 
188-190 
4b C20H24N4O2 
 
352 0.91 Light Brown 
(Crystalline) 
58-60 
4c C21H23N3O3 
 
365 0.89 Pale orange 
(Crystalline) 
193-195 
4d 
 
C20H23N3O2 337 0.93 Pale orange 
(Crystalline) 
189-191 
4e 
 
C21H23N3O4 381 0.93 Pale yellow 
(Crystalline) 
207-209 
 
Table 3: IR Spectra Data of Synthesized Compounds 
 
Compound No. 
 
Wave No.{cm-1} 
1 3367(NH Str.), 2875(C-H), 1656(C=O),  1515(NH bend.), 1195(C-O-C),  744(Ar-H) 
2 2902(C-H), 1697,1647 (C=O), 1406(C-N.), 1114(C-C), 1218(C-O), 744(Ar-H) 
3 3359 (NH Str.),  3056 (Ar-H str.), 2902(C-H), 1697, 1650(C=O), 1604 (C=C Ar.),  1500, 1361(C-N.),  744(Ar-
H bend.) 
4a 3313(NH Str.), 3132 (Ar-H str.), 2843(C-H Str.), 1703(C=O), 1632 (C=CAr.) 1505(NH bend.), 1351(C-N.) 
4b  3050,742(Ar-H), 1642(C=O),  1403(C-H Bend),1195 (C-O), 1105 (C-N.), 
4c 3128(NH Str.), 3128,873(Ar-H), 2993,1401(C-H),1196 (C-N.), 1690(C=O), 1640(NH bend.), 1640 (C= CAr) 
4d 3059,742(Ar-H), 2902,1492(C-H)  1721(C=O), 1555, 1382(C-N.) 
4e 3055,732(Ar-H),1639(C=O),1109 (C-N.), 1402(C-H Bend),1189 (C-O) 
 
CONCLUSION 
The research work was aimed to synthesize novel 
benzoxazinone derivatives, review of literature reveals 
various biological activities for the chemical compounds 
containing benzoxazinone nucleus based on these 
observation it was planned to synthesize such derivatives of 
benzoxazinone that may be of interest. 
Chemistry of benzoxazinone is as old as recorded history. 
The compounds encompassing benzoxazinone moiety are of 
great interest and have been extensively used in 
pharmaceutical chemistry and agriculture division. 
Heterocyclic bearing a benzoxazinone ring residue are 
reported to show anticancer, anti-inflammatory, analgesic, 
muscle-relaxant, sedative, antitubercular, antimicrobial, 
anticonvulsant, antimalarial, antiviral, antioxidant, CNS 
depressant, and plant growth regulatory activity etc. In 
addition, benzoxazinone forms an important pharmacaphore 
in fungicidal, herbicidal and insecticidal, agents.  
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